Kamilla Miskowiak

Kamilla Miskowiak

Professor

ORCID: 0000-0003-2572-1384

Publication year:
All
1 - 6 out of 6Page size: 10
  1. 2014
  2. Published

    A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report

    Gurvich, A., Begemann, M., Dahm, L., Sargin, D., Miskowiak, Kamilla & Ehrenreich, H., Dec 2014, In: Bipolar Disorders (English Edition, Online). 16, 8, p. 881-8 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial

    Miskowiak, Kamilla, Ehrenreich, H., Christensen, E. M., Kessing, Lars Vedel & Vinberg, Maj, Dec 2014, In: Journal of Clinical Psychiatry. 75, 12, p. 1347-1355 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Serotonin transporter genotype, salivary cortisol, neuroticism and life events: impact on subsequent psychopathology in healthy twins at high and low risk for affective disorder

    Vinberg, Maj, Miskowiak, Kamilla & Kessing, Lars Vedel, 3 Jan 2014, In: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 48, p. 193-198 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder

    Vinberg, Maj, Miskowiak, Kamilla & Kessing, Lars Vedel, Jan 2014, In: Psychoneuroendocrinology. 39, p. 179-83 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    'Hot' cognition in major depressive disorder: a systematic review

    Miskowiak, Kamilla & Carvalho, A. F., 2014, In: C N S & Neurological Disorders - Drug Targets. 13, 10, p. 1787-803 17 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

    Miskowiak, Kamilla, Vinberg, Maj, Christensen, E. M., Bukh, J. O. D., Harmer, C. J., Ehrenreich, H. & Kessing, Lars Vedel, 2014, In: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 39, 6, p. 1399-1408 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 17430636